The Correlation between Fetal Hemoglobin and Outcome in Non-Hodgkin's Lymphoma

Miles D.K. , Freedman M.H. , Stephens K. . Patterns of hematopoietic lineage. Involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. Blood 1996; 88: 4314–20.

Sires U.I. , Mallory S.B. , Hess J.L. . Cutaneous presentation of juvenile chronic myelogenous leukemia: A diagnostic and therapeutic dilemma. Pediatr Dermatol 1995; 12: 364–8.

Rautonen J. , Marti A.S. . Initial blood fetal hemoglobin concentration is elevated and is associated with prognosis in children with acute lymphoid or myeloid leukemia. Blut 1990; 61: 17–20.

Wolk M. , Kieselstein M. , Ben-Dor C.G. , Brufman G. . Fetal hemoglobin screening in whole blood and in plasma of cancer patients. Tumour Biol 1991; 12: 45–51.

Wolk M. , Newland A.C. , De la Salle B. . Refinement of plasma fetal hemoglobin (HbF) measurements, as related to whole blood HbF, in cancer patients. J Tumor Marker Oncol 1999; 14: 115–26.

Wolk M. , Martin J.E. , Constantin R. . Blood cells with fetal haemoglobin (F-cells) detected by immunohistochemistry as indicators of solid tumors. J Clin Pathol 2004 (accepted for publication).

Carr B.I. , Rahbar S. , Doroshow J.H. . Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma. Cancer Res 1987; 47: 4199–201.

Wolk M. , Kieselstein M. , Brufman G. . Evaluation of fetal hemoglobin in various malignancies with reference to the patients’ age. Tumour Biol 1988; 9: 95–100.